TrialJournal of Korean medical science2012

The dipeptidyl peptidase-4 inhibitor sitagliptin improves vascular endothelial function in type 2 diabetes.

Yoshiaki Kubota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.